Sector: Health Care
Director information for RESMED INC (data for year 2025)
| Name | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| Carol Burt | Director; Principal of Burt-Hilliard Investments and Senior Advisor and Member of the Operating Council for Consonance Capital Partners; Chair of Nominating and Governance Committee; Other Member; Chair of the Nominating and Governance Committee | 67 | ["Extensive executive management and board leadership", "Extensive experience in the healthcare insurance, healthcare provider, medical technology, and financial services industries", "Current Public Company Directorships: IQVIA Holdings Inc. (2019-present), Chair of the Leadership Development and Compensation Committee, Member of the Audit Committee", "Prior Public Company Directorships: Envision Healthcare Corp., Vanguard Health Systems Inc., WellCare Health Plans, Inc.", "Key role in risk oversight"] | ["A", "O", "Audit", "Compliance, Privacy and Quality", "Nominating and Governance (Chair)", "Nominating and Governance Committee", "Audit Committee", "Compliance, Privacy and Quality Committee"] | 2025 |
| Christopher DelOrefice | Executive Vice President and Chief Financial Officer of Becton, Dickinson and Company; Director; Chair of Audit Committee; Chair of the Audit Committee | 54 | ["Experienced finance executive in medical technology", "Including commercial, long-term strategy, investor relations, supply chain, mergers and acquisitions, and global R&D"] | ["Audit Committee"] | 2025 |
| Desney Tan | Corporate Vice President and Managing Director of Microsoft Research; Member | 49 | ["Experience in digital health technologies", "Use of machine learning and artificial intelligence", "Global R&D in devices, hardware and consumer products"] | ["C", "N", "Nominating and Governance Committee"] | 2025 |
| Harjit Gill | Chief Executive Officer of the Asia Pacific Medical Technology Association; Director; Chair of Compliance, Privacy and Quality Committee; Other Member; Chair of the Compliance, Privacy and Quality Committee | 60 | ["Executive and operational background in consumer healthcare", "Sales, marketing, and international operations"] | ["A", "C", "Compliance, Privacy and Quality Committee"] | 2025 |
| Jan De Witte | Director; Operating Partner of GHO Capital Partners LLP; Other Member | 61 | ["30 years in executive management, corporate strategy and operations for technology and software businesses", "Extensive experience in international business", "Experience as an operating CEO and director in medical technology", "Current Public Company Directorships: Elekta", "Prior Public Company Directorships: BARCO (2016-2021), Integra Life Sciences (2021 - 2025)"] | ["A", "O", "Audit", "Compliance, Privacy and Quality"] | 2025 |
| John Hernandez | Head of Health Impact at Google; Director; Other Member | 58 | ["Experience at the intersection of big tech and healthcare", "Including use of artificial intelligence", "Widely published and frequent lecturer on digital health strategy and use of real-world evidence"] | ["O"] | 2025 |
| Justin Leong | Chief Product Officer | ["Chief product officer with experience in product management, hardware and software engineering, and business development", "Former president of Resmed\u2019s Asia and Latin American markets", "Experience at HgCapital and Bain & Co.", "Holds a Bachelor of Commerce and a Bachelor of Laws, and an MBA from Harvard Business School"] | [] | 2025 | |
| Karen Drexler | Former Chief Executive Officer of Sandstone Diagnostics, Inc.; Director; Former Board Member and Chief Executive Officer of Sandstone Diagnostics, Inc.; Chair of Compensation and Leadership Development Committee | 65 | ["Founder, executive and board experience in the medical diagnostics and device industries", "Particularly in digital health, technology, and out-of-hospital care models", "Former Board Member and Chief Executive Officer of Sandstone Diagnostics, Inc.", "Current Public Company Directorships: Outset Medical (NASDAQ: OM)", "Current Public Company Directorships: EBR Systems, Inc. (ASX: EBR)", "Prior Public Company Directorships: Tivic Health (NASDAQ:TIVC)"] | ["N", "Compensation and Leadership Development (Chair)", "Nominating and Governance"] | 2025 |
| Michael “Mick” Farrell | Chairman of the Board and Chief Executive Officer of ResMed Inc. | 53 | ["25+ years of experience with Resmed", "29+ years of experience in healthcare and technology industries", "Deep understanding of products, operations, technology, sales and marketing", "Chairman of the Board and Chief Executive Officer of ResMed Inc.", "Lead independent director at Zimmer Biomet", "Member of the compensation and management development committee", "Member of the quality, regulatory and technology committee"] | [] | 2025 |
| Nicole Mowad-Nassar | Senior Vice President of AbbVie Inc., and President of Global Allergan Aesthetics; Director | 54 | ["Extensive experience in big pharma", "Currently leading a major division for AbbVie", "Experience in commercial strategy, marketing, digital health innovation, patient access, market access and enterprise integration"] | ["C"] | 2025 |
| Peter Farrell | Founder and Chairman Emeritus of ResMed Inc.; Founder, chairman emeritus and non-executive employee | 83 | ["Resmed founder and chief executive officer for 20+ years", "Deep understanding of operations, technology, and sleep industry", "Significant board experience with other publicly-held medical technology companies", "Founder and Chairman Emeritus of ResMed Inc.", "Current Board Member of Arcturus Therapeutics Holdings Inc.", "Former Board Chair of NuVasive, Inc.", "Experience with compensation and nominating and corporate governance committees"] | [] | 2025 |
| Richard Sulpizio | Other Member | [] | [] | 2025 | |
| Ronald “Ron” Taylor | Founder and Chief Executive Officer of Pyxis Corporation Lead Director; Lead Independent Director; Other Member | 77 | ["Public medical technology company founder and CEO", "Has served on over twenty public and private boards", "Venture capital experience evaluating healthcare companies", "Founder and Former Chairman and Chief Executive Officer of Pyxis Corporation", "Prior Public Company Directorships: Allergan, Medicalogic, Red Lion Hotels", "financially literate", "financial expert"] | ["N", "A", "O", "Audit", "Compliance, Privacy and Quality", "Nominating and Governance", "Audit Committee", "Nominating and Governance Committee", "Compliance, Privacy and Quality Committee"] | 2025 |
| Scott Rosen | Chairman Emeritus | ["Founder, former Chairman of the Board, and former Chief Executive Officer of Resmed", "B.E. in chemical engineering with honors from the University of Sydney", "S.M. in chemical engineering from MIT", "Ph.D. in chemical engineering and bioengineering from the University of Washington, Seattle", "D.Sc. from the University of New South Wales", "Visiting professor and chair of the UNSW Centre for Innovation and Entrepreneurship", "Serves on the MIT Dean of Engineering Advisory Council"] | [] | 2025 |
